P593-0512 Screening compound: 3-[(4-phenylpiperazin-1-yl)sulfonyl]-1-[(pyridin-2-yl)methyl]-1H-pyrazole-4-carboxylic acid

P593-0512 Screening compound: 3-[(4-phenylpiperazin-1-yl)sulfonyl]-1-[(pyridin-2-yl)methyl]-1H-pyrazole-4-carboxylic acid
P593-0512 Screening compound: 3-[(4-phenylpiperazin-1-yl)sulfonyl]-1-[(pyridin-2-yl)methyl]-1H-pyrazole-4-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound P593-0512
3-[(4-phenylpiperazin-1-yl)sulfonyl]-1-[(pyridin-2-yl)methyl]-1H-pyrazole-4-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P593-0512

Molecular Formula

C20H21N5O4S (C20 H21 N5 O4 S)

Compound Name

3-[(4-phenylpiperazin-1-yl)sulfonyl]-1-[(pyridin-2-yl)methyl]-1H-pyrazole-4-carboxylic acid

IUPAC name

3-[(4-phenylpiperazin-1-yl)sulfonyl]-1-[(pyridin-2-yl)methyl]-1H-pyrazole-4-carboxylic acid

SMILES

OC(c1cn(Cc2ncccc2)nc1S(N(CC1)CCN1c1ccccc1)(=O)=O)=O

InChI

InChI=1S/C20H21N5O4S/c26-20(27)18-15-24(14-16-6-4-5-9-21-16)22-19(18)30(28,29)25-12-10-23(11-13-25)17-7-2-1-3-8-17/h1-9,15H,10-14H2,(H,26,27)

InChI Key

PXWFJHHZYMWPTQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD22596981

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

427.48

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.665

Distribution Coefficient, logD

-2.154

Water Solubility, LogSw

-2.49

Polar Surface Area

87.988

Acid Dissociation Constant (pKa)

3.58

Base Dissociation Constant (pKb)

4.84

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

P593-0512 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P593-0512 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P593-0512?
Check Price and Availability of P593-0512, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P593-0512 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P593-0512
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P593-0512
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P593-0512 available by request